Ishiyama-Shigemoto S, Yamada K, Yuan X, Koyama W, Nonaka K
Department of Medicine, Kurume University School of Medicine, Japan.
Diabet Med. 1998 Oct;15(10):826-9. doi: 10.1002/(SICI)1096-9136(199810)15:10<826::AID-DIA685>3.0.CO;2-H.
To assess the association of polymorphisms at the sulphonylurea receptor (SUR1) gene with the development of Type 2 diabetes mellitus, 456 subjects, 236 with Type 2 diabetes and 220 non-diabetic controls, were analysed for variants at exon 7, exon 22 and intron 24 of the SUR1 gene by the polymerase chain reaction and restriction fragment length polymorphism. The T761T substitution in exon 22 of the SUR1 gene was not found in either diabetic patients or non-diabetic controls. Both the exon 7 variant and the intron 24 variant were present in both groups at similar frequencies. No significant association was seen between either variant and obesity. Diabetic patients homozygous for the -3C allele of intron 24 had a higher ratio of positive family history than patients homozygous for the -3T allele (p = 0.03). We conclude that these polymorphisms are not major determinants of diabetes and obesity in the Japanese population.
为评估磺脲类受体(SUR1)基因多态性与2型糖尿病发生之间的关联,我们采用聚合酶链反应和限制性片段长度多态性方法,对456名受试者(236例2型糖尿病患者和220名非糖尿病对照者)的SUR1基因第7外显子、第22外显子和第24内含子的变异情况进行了分析。在糖尿病患者和非糖尿病对照者中均未发现SUR1基因第22外显子的T761T替换。第7外显子变异和第24内含子变异在两组中的出现频率相似。两种变异与肥胖之间均未发现显著关联。第24内含子-3C等位基因纯合的糖尿病患者的阳性家族史比例高于-3T等位基因纯合的患者(p = 0.03)。我们得出结论,在日本人群中,这些多态性并非糖尿病和肥胖的主要决定因素。